Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Alejandro Aballay Image

      Alejandro Aballay, PhD

      Department of Genetics, Division of Discovery Science

      About Dr. Alejandro Aballay

      Dr. Alejandro Aballay is Professor, Department of Genetics, MD Anderson Cancer Center, Professor, Department of Microbiology and Molecular Genetics, McGovern Medical School at UT Health Houston and Dean of the Graduate School of Biomedical Sciences. Before joining MD Anderson and the Graduate School of Biomedical Sciences, Dr. Aballay was Professor and Chair of Molecular Microbiology and Immunology at OHSU. Prior to OHSU, Dr. Aballay was Professor in Molecular Genetics and Microbiology and Center Director at Duke University Medical Center. Dr. Aballay received his Ph.D. in Molecular and Cell Biology from the Nacional de Cuyo University Medical School in Mendoza, Argentina, in 1998. He completed a postdoctoral fellowship at the Washington University School of Medicine, in 1999, on intracellular trafficking. He completed a second postdoctoral fellowship at Massachusetts General Hospital and the Department of Genetics, Harvard Medical School, in 2002, on molecular pathogenesis. Dr. Aballay joined the Duke faculty in 2002 and launched a multidisciplinary research program studying neural circuits involved in the control of stress responses and innate immunity. His team also studies the effects of inflammation on the nervous system. Dr. Aballay has published in Science, Developmental Cell, PNAS. eLife, and Current Biology. He is a fellow of the American Academy of Microbiology, AAAS and a member of multiple editorial boards, including Virulence, Journal of Pathogens, Frontiers in Microbial Immunology, and mBio. He has served on a number of grant review panels for the National Science Foundation and NIH. He has received a prestigious NIH MERIT Award from the National Institute of General Medical Sciences for his research project on the role of the nervous system in controlling immunity.

      Read More

      In the News

      Representative image of bacteria

      Circadian rhythms may affect risk of bacterial infection

      Present Title & Affiliation

      Primary Appointment

      Dean-GSBS Sciences, The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX

      Professor, Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX

      Professor (Joint appointment), Department of Microbiology and Molecular Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Dean-GSBS Sciences, The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX

      Professor, Deptment of Microbiology and Molecular Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX

      Professor, Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX

      Research Interests

      Alejandro Aballay's lab has a broad research program encompassing genetics, functional genomics and neurobiological approaches to study mechanisms involved in the control of immune responses against microbial pathogens. Immune activation needs to be fine-tuned since deficient or excessive inflammation can lead to cancer or other conditions such as Crohn’s disease, rheumatoid arthritis, atherosclerosis, diabetes and Alzheimer’s disease.

      Recent studies from Aballay Lab indicate that different immune and cellular homeostatic mechanisms are regulated at the organismal level by the nervous system. The lab's research has demonstrated that specific neurons suppress innate immunity in the intestinal cells of the nematode Caenorhabditis elegans, in part by down-modulating a mitogen-activated protein kinase signaling pathway similar to the mammalian p38 MAPK pathway that is highly conserved across metazoans. The lab found that G-protein coupled receptors (GPCRs) participate in neural circuits that control a conserved p38/PMK-1 MAPK immune pathway and non-canonical and canonical XBP-1 unfolded protein response pathways that are expressed in non-neuronal tissues and that are necessary to alleviate the increased demand on protein folding during immune activation.

      Education & Training

      Degree-Granting Education

      1998Nacional de Cuyo University Medical School, Mendoza, AR, Molecular and Cell Biology, Ph.D
      1997Washington University School of Medicine, St. Louis, Missouri, US, Graduate Student Fellow, Ph.D
      1995Nacional de Cuyo University Medical School, Mendoza, AR, Molecular and Cell Biology, M.S
      1994Juan Agustín Maza University, Mendoza, AR, Pharm. D, PHARMD

      Postgraduate Training

      1999-2002Postdoctoral, Molecular Pathogenesis. Department of Molecular Biology, Massachusetts General Hospital and Department of Genetics, Harvard Medical School, Boston, Massachusetts
      1999-2002Research Fellow, Harvard Medical School, Boston, Massachusetts
      1998-1999Postdoctoral, Intracellular Trafficking. Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri
      1998-1999Research Fellow, Washington University, St. Louis, Missouri
      1996-1997Graduate Student Fellow, Washington University School of Medicine, St. Louis, Missouri
      1995-1998Graduate Student, National Council for Research, Nacional de Cuyo University Medical School, Mendoza
      1995-1998Lecturer, Nacional de Cuyo University Medical School, Mendoza
      1994-1998Lecturer, Juan A. Maza University, Mendoza

      Experience & Service

      Faculty Academic Appointments

      Professor and Chair, Oregon Health & Science University, Portland, OR, 2017 - 2024

      Adjunct Professor, Duke University Medical Center, Durham, NC, 2017 - 2021

      Professor, Duke University Medical Center, Durham, NC, 2016 - 2017

      Director, Duke University Medical Center, Durham, NC, 2014 - 2017

      Associate Professor, Duke University Medical Center, Durham, NC, 2009 - 2016

      Assistant Professor, Duke University Medical Center, Durham, NC, 2002 - 2009

      Editorial Activities

      Member of Editorial Review Board, BIOCEL, 2018 - 2020

      Member of Editorial Review Board, mBio, 2017 - 2026

      Member of Editorial Review Board, Journal of Genetics and Genome Research, 2014 - Present

      Associate Guess Editor, PLOS Genetics, 2013 - 2018

      Member of consulting, Journal of Clinical Investigation, 2012 - 2017

      Member of Editorial Review Board, Frontiers in Microbial Immunology, 2010 - Present

      Member of Editorial Review Board, Journal of Pathogens, 2010 - Present

      Member of Editorial Review Board, Virulence, 2010 - 2018

      Member of Editorial Review Board, International Journal of Physiology, Pathology and Pharmacology, 2009 - Present

      Member of Editorial Review Board, PLOS ONE, 2006 - 2018

      Honors & Awards

      2024John P. McGovern Graduate School of Biomedical Sciences Endowed Distinguished Professorship, UT Health Houston
      2017American Academy of Microbiology Fellow
      2017Maximizing Investigator Research Award (MIRA), NIH
      2017William A. Whitsell Dean’s Leadership Professorship. Oregon Health & Science University
      2016Dean’s Suite wall of faculty members who have reached extraordinary levels of accomplishment. Noted for identifying the first neural circuits involved in the control of innate immunity at whole animal level. Duke University Medical Center
      2014Chancellor’s Discovery Award Program. Duke University Medical Center
      2013American Association for the Advancement of Science (AAAS) Fellow
      2009Dana Foundation. Neuroimmunology of Brain Infections and Cancers Award
      2008 - 2009Chancellor's Science Advisory Council Award. Duke University Medical Center
      2005HIC Small Innovative Project Award. Duke Center for Translational Research
      2005ICAAC Young Investigator Award. American Society for Microbiology (ASM)
      2004SERCEB Biodefense and Emerging Infections Career Development and Education Award. Southeast Regional Center of Excellence for Emerging Infections & Biodefense (SERCEB/NIH)
      2003 - 2008Whitehead Scholar in Biomedical Sciences at Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC
      2001 - 2003Medical Foundation Postdoctoral Fellowship at Department of Molecular Biology, Massachusetts General Hospital and Genetics, Harvard Medical School
      2000 - 2001Massachusetts General Hospital Funding for Medical Discovery Postdoctoral Fellowship at Department of Molecular Biology, Massachusetts General Hospital and Genetics, Harvard Medical School
      1998 - 2000Pew Foundation Postdoctoral Fellowship at Department of Cell Biology and Physiology, Washington University School of Medicine and Department of Molecular Biology, Massachusetts General Hospital and Genetics, Harvard Medical School
      1997Washington University Fellowship. Characterization of the Rab11 function in endocytosis. Three months of training at the Department of Cell Biology and Physiology, Washington University School of Medicine
      1996The American Society for Cell Biology/International Federation on Cell Biology Travel Award. 6th International Congress on Cell Biology
      1996World Bank Fellowship. Mutagenesis of Rab22. Three months of training at the Department of Cell Biology and Physiology, Washington University School of Medicine
      1995 - 1998National Council for Scientific and Technical Research (CONICET) Predoctoral Fellowship, Argentina

      Professional Memberships

      Advisory Committee for T32 Interdisciplinary Training in Cancer Research, Fred Hutchinson Cancer Center

      2023 - Present

      Steering Committee for T90/R90 on Microbial Pathogenesis, School of Dentistry, Oregon Health & Science University

      2021 - Present

      Steering Committee for T32 on Host-Pathogen interaction, Oregon Health & Science University

      2019 - 2021

      Search Committee for Assistant Dean for Faculty Development, Oregon Health & Science University

      2019

      Search Committee for Chair of Anesthesiology and Perioperative Medicine, Oregon Health & Science University

      2019

      Search Committee for Infectious Disease Chief, Oregon Health & Science University

      2019

      Search Committee for Assistant Dean for Faculty Development, Oregon Health & Science University

      2019

      OHSU Faculty Honors Committee

      2018 - 2021

      Self-Study Committed for Liaison Committee for Med Education (LCME) tasked with assessing the following: mission, planning, organization, and integrity; leadership and administration; educational resources and infrastructure. Oregon Health & Science Univ

      2018

      Search Committee for Senior Associate Dean for Research, Oregon Health & Science University

      2018

      Basic Science Council. School of Medicine, Oregon Health Science University

      2017 - Present

      Collaborative Research Leadership Group. Oregon Health Science University

      2017 - 2018

      Self-Study Committed for Liaison Committee for Med Education (LCME) tasked with assessing the following: faculty development and mentoring, Duke University Medical Center

      2017

      Functional Genomics Core Committee. Duke University Medical Center

      2016 - 2017

      School of Medicine Faculty Honors Committee. Duke University Medical Center

      2016 - 2017

      School of Medicine Inclusion Council. Duke University Medical Center

      2014 - 2017

      Provost’s Faculty Diversity Standing Committee. Duke University

      2014 - 2015

      Faculty Search Committee. Department of Molecular Genetics and Microbiology. Duke University Medical Center

      2012 - 2013

      Academic Council of Duke University. Basic Sciences-Medicine Division. Duke University

      2010 - 2013

      Executive Committee of the University Program in Genetics and Genomics Seminar Series. Duke University Medical Center

      2009 - 2017

      University Program in Genetics and Genomics Seminar Series. Duke University Medical Center

      2009 - 2015

      Medical School Microbiology Course. Duke University Medical Center

      2009 - 2012

      Faculty Search Committee. Department of Molecular Genetics and Microbiology. Duke University Medical Center

      2009 - 2010

      Advisory Committee for the Department of Molecular Genetics and Microbiology. Duke University Medical Center

      2009 - 2010

      Duke SoM Bridge Fund Applications. Duke University Medical Center

      2009

      RNAi Core Committee. Duke Institute for Genome Sciences & Policy Center for Applied Genomics & Technology

      2008 - 2011

      Microarray User Committee. Duke Institute for Genome Sciences & Policy Center for Applied Genomics & Technology

      2008 - 2010

      Graduate Program Service: CMB Graduate Program Advisory Committee. Duke University Medical Center

      2007

      Graduate Program Service: CMB Graduate Program Advisory Committee. Duke University Medical Center

      2006

      Graduate Program Service: MSTP Admissions Committee. Duke University Medical Center

      2005 - 2013

      Search Committee for Institutional Leader at Duke in Emerging Infections and Biodefense. Southeast Regional Center of Excellence for Biodefense and Emerging Infections (SERCEB)

      2005 - 2006

      Tuesday Seminars. Duke University Medical Center

      2004 - 2009

      Summer Research Opportunities Program for Minorities. Duke University Medical Center

      2003 - 2007

      Graduate Program Service: Molecular Genetics and Microbiology Graduate Program. Duke University Medical Center

      2002 - 2009

      Selected Presentations & Talks

      National Presentations

      1. 2020. 2020 C. elegans Metabolism, Aging, Pathogenesis, Stress and Small RNAs (MAPS) meeting. Invited. 2020 C. elegans Metabolism, Aging, Pathogenesis, Stress and Small RNAs (MAPS) meeting. Wisconsin, Madison, US.
      2. 2019. FASEB Molecular Pathogenesis: Mechanisms of Infectious Disease. Invited. FASEB Molecular Pathogenesis: Mechanisms of Infectious Disease, CO, US.
      3. 2019. Keynote Speaker at 2019 Northwest Worm Meeting. Invited. Keynote Speaker at 2019 Northwest Worm Meeting. Washington, DC, US.
      4. 2013. FASEB Meeting: From Unfolded Proteins in the ER to Disease. Invited. Vermont Academy. Saxtons River, VT, US.
      5. 2013. Insights and Solutions for Emerging Infectious Diseases. Neural regulation of pathogen recognition and immune activation. Invited. Insights and Solutions for Emerging Infectious Diseases. Neural regulation of pathogen recognition and immune activation. Durham, NC, US.
      6. 2011. 5th Annual Center for Human Immunology Symposium. September 15, 2011. Intelligent command of defenses: Neural regulation of pathogen recognition and immune activation. Invited. 5th Annual Center for Human Immunology Symposium. September 15, 2011. Intelligent command of defenses: Neural regulation of pathogen recognition and immune activation. Milwaukee, WI, US.
      7. 2008. Gordon Conference: Microbial Toxins and Pathogenicity. Unfolded protein response genes regulated by CED-1 are required for Caenorhabditis elegans innate immunity. Invited. Proctor Academy. Andover, NH, US.
      8. 2007. Southeast Regional Center of Excellence for Emerging Infections and Biodefense. Annual Meeting. Drug Discovery and High Throughput Technology. Invited. Southeast Regional Center of Excellence for Emerging Infections and Biodefense. Annual Meeting. Drug Discovery and High Throughput Technology. Nashville, TN, US.
      9. 2007. 4th Annual NIAID RCE Research Meeting. Genetic analysis of innate immunity to Y. pestis using C. elegans as model host. Invited. 4th Annual NIAID RCE Research Meeting. Genetic analysis of innate immunity to Y. pestis using C. elegans as model host. St Louis, MO, US.
      10. 2006. American Society for Cell Biology 2006. Genetic pathways that regulate stress response, aging, and immunity in Caenorhabditis elegans. “Novel & Newsworthy Top Pick". Invited. American Society for Cell Biology 2006. Genetic pathways that regulate stress response, aging, and immunity in Caenorhabditis elegans. “Novel & Newsworthy Top Pick". San Diego, CA, US.
      11. 2006. Regional Centers for Biodefense and Emerging Infectious Diseases Research. Fourth Annual Meeting. Mechanisms to boost immunity to Y. pestis. Invited. Regional Centers for Biodefense and Emerging Infectious Diseases Research. Fourth Annual Meeting. Mechanisms to boost immunity to Y. pestis. Gainesville, FL, US.
      12. 2006. Gordon Conference: Microbial Toxins and Pathogenicity. Genetic pathways that regulate the expression of conserved effectors of the C. elegans immune system (Poster). Invited. Proctor Academy. Andover, NH, US.
      13. 2006. Regional Centers for Biodefense and Emerging Infectious Diseases Research. Third Annual Meeting. Genetic analysis of innate immunity to Y. pestis using C. elegans as model host. Invited. Regional Centers for Biodefense and Emerging Infectious Diseases Research. Third Annual Meeting. Genetic analysis of innate immunity to Y. pestis using C. elegans as model host. New York City, NY, US.
      14. 2005. Gordon Conference: Molecular Mechanisms of Microbial Adhesion. Characterization of the CED-3-mediated immune response against Salmonella enterica (Poster). Invited. Salve Regina University. Newport, RI, US.
      15. 2005. SERCEB Immunology Workshop. C. elegans as a model host to study bacterial pathogenesis and innate immunity. Invited. SERCEB Immunology Workshop. C. elegans as a model host to study bacterial pathogenesis and innate immunity. Chapel Hill, NC, US.
      16. 2005. Regional Centers for Biodefense and Emerging Infectious Diseases Research. Second Annual Meeting. C. elegans as host to study Y. pestis pathogenesis. Invited. Regional Centers for Biodefense and Emerging Infectious Diseases Research. Second Annual Meeting. C. elegans as host to study Y. pestis pathogenesis. Galveston, TX, US.
      17. 2005. Distinguished Speaker Series. NIH Genetics Training Grant at the University of Michigan. “C. elegans as a model host to study host-pathogen interactions”. Invited. University of Michigan Medical School. Ann Arbor, MI, US.
      18. 2004. COBRE in Lipidomics & Pathobiology: Mini-Symposium on Lipid-mediated Infectious Diseases. Study of innate immunity and bacterial pathogenesis using C. elegans. Invited. Medical University of South Carolina. Charleston, SC, US.
      19. 2004. Gordon Conference: Microbial Toxins and Pathogenicity. Study of conserved host-pathogen interactions at the molecular level using C. elegans and S. enterica (Poster). Invited. Proctor Academy. Andover, NH, US.
      20. 2003. Toxicogenomics Research Consortium Bi-Annual Meeting. Genetic Study of C. elegans Innate Immune Response. Invited. Toxicogenomics Research Consortium Bi-Annual Meeting. Genetic Study of C. elegans Innate Immune Response. Seattle, WA, US.
      21. 2002. Gordon Conference: Microbial Stress Response. Caenorhabditis elegans innate immune response triggered by Salmonella enterica requires intact LPS and is mediated by a MAPK signaling pathway (Poster). Invited. Salve Regina University. Newport, RI, US.
      22. 2001. 7th Annual Boston Bacterial Meeting. Caenorhabditis elegans as a model host for human bacterial pathogens. Invited. 7th Annual Boston Bacterial Meeting. Caenorhabditis elegans as a model host for human bacterial pathogens. Boston, MA, US.

      International Presentations

      1. 2023. 3rd Latin American Worm Meeting. Invited. 3rd Latin American Worm Meeting. Valparaiso, CL.
      2. 2022. 6rd International Conference on Model Hosts. Invited. 6rd International Conference on Model Hosts. Rhodes, GR.
      3. 2020. 12th FENS Forum of Neuroscience. Invited. 12th FENS Forum of Neuroscience. Glasgow, GB.
      4. 2017. 4rd International Conference on Model Hosts. Invited. 4rd International Conference on Model Hosts. Rhodes, GR.
      5. 2016. Keynote Speaker at 10th Scientific Federation Conference: World Congress and Expo on Immunology. Invited. Keynote Speaker at 10th Scientific Federation Conference: World Congress and Expo on Immunology. Dubai, AE.
      6. 2015. 3rd International Conference on Model Hosts. Organismal control of defense responses and recovery from infections in C. elegans. Invited. 3rd International Conference on Model Hosts. Organismal control of defense responses and recovery from infections in C. elegans. Chania, GR.
      7. 2014. Pew Meeting. Invited. Pew Meeting. Herradura, CR.
      8. 2013. Gordon Conference: New Opportunities with G-protein Coupled Receptors/From Single Molecules and Signaling Complexes to Physiology and Therapeutic Interventions. Invited. Gordon Conference: New Opportunities with G-protein Coupled Receptors/From Single Molecules and Signaling Complexes to Physiology and Therapeutic Interventions. Lucca, IT.
      9. 2012. 2nd International Conference on Model Hosts. Neural regulation of proteostasis during immune activation. Invited. 2nd International Conference on Model Hosts. Neural regulation of proteostasis during immune activation. Rhodes, GR.
      10. 2011. 8th International Conference on Innate Immunity. Neuronal G-protein coupled catecholamine receptor controls innate immunity by regulating unfolded protein response genes. Invited. 8th International Conference on Innate Immunity. Neuronal G-protein coupled catecholamine receptor controls innate immunity by regulating unfolded protein response genes. Crete, GR.
      11. 2010. 1st International Conference on Model Hosts. Intelligent command of defenses: Neural regulation of pathogen recognition and immune activation. Invited. 1st International Conference on Model Hosts. Intelligent command of defenses: Neural regulation of pathogen recognition and immune activation. Crete, GR.
      12. 2007. 43th Argentine Society for Biochemistry and Molecular Biology Research (SAIB) Annual Meeting. Cell Biology Symposium. Use of C. elegans to study conserved signaling pathways that regulate innate immunity. Invited. 43th Argentine Society for Biochemistry and Molecular Biology Research (SAIB) Annual Meeting. Cell Biology Symposium. Use of C. elegans to study conserved signaling pathways that regulate innate immunity. Buenos Aires, AR.
      13. 2006. XII Argentine Meeting of Microbiology. Genetic study to identify new Yersinia pestis virulence factors and innate immunity components against this pathogen. Invited. XII Argentine Meeting of Microbiology. Genetic study to identify new Yersinia pestis virulence factors and innate immunity components against this pathogen. Mendoza, AR.
      14. 2005. 15th Biennial International C. elegans Meeting. Chair of Pathogenesis Parallel Session. Invited. 15th Biennial International C. elegans Meeting. Chair of Pathogenesis Parallel Session. Los Angeles, US.
      15. 2003. 14th International C. elegans Meeting. Modeling Innate Immunity in C. elegans Workshop. Invited. 14th International C. elegans Meeting. Modeling Innate Immunity in C. elegans Workshop. Los Angeles, US.
      16. 2001. 13th International C. elegans Meeting. Infection and Immunity Workshop. Invited. 13th International C. elegans Meeting. Infection and Immunity Workshop. Los Angeles, US.
      17. 2000. Pew Annual Meeting. Salmonella typhimurium kills C. elegans by an infectious like process. Invited. Pew Annual Meeting. Salmonella typhimurium kills C. elegans by an infectious like process. Conzumel, MX.

      Formal Peers

      1. 2023. Medical School. Invited. Pullman, WA, US.
      2. 2023. Medical School. Invited. Boston, MA, US.
      3. 2022. Veterinary School. Invited. Pullman, WA, US.
      4. 2021. Genome Science. Invited. Portland, OR, US.
      5. 2019. Feinstein Institute for Medical Research. Invited. New York, NY, US.
      6. 2018. BioSciences Department. Invited, US.
      7. 2018. Department of Molecular Microbiology. Invited, US.
      8. 2017. Vollum Institute. Invited, US.
      9. 2016. Virgen del Rocio Hospital. Invited. Seville, ES.
      10. 2015. Department of Biochemistry and Microbiology. Invited, US.
      11. 2013. Department of Molecular and Cellular Medicine. Invited, US.
      12. 2013. Department of Pharmacology and Cancer Biology. Invited, US.
      13. 2012. Department of Microbiology and Molecular Genetics. Invited, US.
      14. 2012. Department of Animal Sciences. Invited, US.
      15. 2012. Department of Cell Biology. Invited, US.
      16. 2011. Department of Biology. Invited, US.
      17. 2011. Department of Microbiology and Physiological Systems. Invited, US.
      18. 2011. Department of Immunology. Invited, US.
      19. 2011. Medical School. Invited, US.
      20. 2010. Medical School. Invited, US.
      21. 2010. College of Pharmacy. Invited. Minneapolis, MN, US.
      22. 2008. C. elegans course. Invited. New York, NY, US.
      23. 2008. Department of Microbiology. Invited. Chicago, IL, US.
      24. 2007. Division of Immunology-Microbial Pathogenesis. Invited, US.
      25. 2006. North Carolina Pathogenesis Research Group Meeting. Invited. Chapel Hill, NC, US.
      26. 2003. Department of Immunology. Invited, US.
      27. 2002. Department of Molecular Genetics and Microbiology. Invited, US.
      28. 2002. Department of Molecular & Cell Biology. Invited, US.
      29. 2002. Department of Microbiology and Center for Genetics and Development. Invited, US.
      30. 2002. Division of Infectious Diseases. Invited, US.
      31. 2002. Department of Microbiology, Immunology and Molecular Genetics. Invited, US.
      32. 2002. Department of Cell Biology and Anatomy. Invited, US.
      33. 2002. Department of Microbiology. Invited, US.
      34. 2002. Department of Microbiology. Invited, US.
      35. 2001. Department of Microbiology and Immunology and Center for Infectious Diseases. Invited, US.
      36. 2001. School of Medicine. Invited, US.
      37. 1999. School of Medicine. Invited, US.
      38. 1998. Institute of Biochemistry. Invited. Lausanne, CH.
      39. Department of Pathology. Invited. Salt Lake City, UT, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2023 - 2028
      Title:Founding Director of the Interdisciplinary Training in Microbial Pathogenesis and Immunology
      Funding Source:NIH/NIGMS
      Role:PI
      Date: 2020 - 2025
      Title:Mechanism of innate immune activation by intestinal distension
      Funding Source:NIH/NIAID
      Role:PI
      ID:R01 AI156900-01
      Date: 2018 - 2019
      Title:Genetic analysis of innate immunity using C. elegans
      Funding Source:NIH/NIGMS
      Role:PI
      ID:3R01 GM070977-16S1
      Date: 2017 - 2027
      Title:Genetic analysis of innate immunity using C. elegans
      Funding Source:NIH/NIGMS
      Role:PI
      ID:2R01 GM070977-18
      Date: 2017 - 2022
      Title:Founding Director of the Duke’s Interdisciplinary Program in Host-Microbial Interactions
      Funding Source:NIH/NIAID
      Role:PI
      Date: 2016 - 2017
      Title:Genetic analysis of innate immunity using C. elegans
      Funding Source:NIH/NIGMS
      Role:PI
      ID:3R01GM070977-13S1
      Date: 2015 - 2020
      Title:C. elegans to study organismal control of recovery from bacterial infections
      Funding Source:NIH/NIAID
      Role:PI
      Date: 2009 - 2013
      Title:Genetic analysis of innate immunity using C. elegans
      Funding Source:NIH/NIGMS
      Role:PI
      Date: 2004 - 2017
      Title:Genetic analysis of innate immunity using C. elegans
      Funding Source:NIH/NIGMS
      Role:PI
      ID:5R01 GM070977-12
      Title:Construction of a BSL-3 laboratory to provide the necessary laboratory infrastructure for basic scientists and physician-scientists with common interests in immunology and infectious diseases
      Funding Source:NIH ORIP Biomedical Research Facilities
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Lalsiamthara, J, Locke, M, Aballay, A. Circadian-shaped immune variability predicts infection outcome. Science Advances 12(1):1-13, 2026. e-Pub 2026. PMID: 41477859.
      2. Otarigho, B, Aballay, A. Neurotransmitter signaling in molecular and behavioral immune responses to pathogens in C. elegans. Microbiology and Molecular Biology Reviews 89(4), 2025. e-Pub 2025. PMID: 40932387.
      3. Otarigho B, Butts AF, Aballay A. Neuronal NPR-15 modulates molecular and behavioral immune responses via the amphid sensory neuron-intestinal axis in C. elegans. Elife 12, 2024. e-Pub 2024. PMID: 38446031.
      4. Kaur S, Selden NR, Aballay A. Anti-inflammatory effects of vagus nerve stimulation in pediatric patients with epilepsy. Front Immunol 14:1093574, 2023. e-Pub 2023. PMID: 36845140.
      5. Ren J, Sang Y, Aballay A. Cholinergic receptor-Wnt pathway controls immune activation by sensing intestinal dysfunction. Cell Rep 41(5):111575, 2022. e-Pub 2022. PMID: 36323254.
      6. Filipowicz A, Lalsiamthara J, Aballay A. Dissection of a sensorimotor circuit underlying pathogen aversion in C. elegans. BMC Biol 20(1):229, 2022. e-Pub 2022. PMID: 36209082.
      7. Lalsiamthara J, Aballay A. The gut efflux pump MRP-1 exports oxidized glutathione as a danger signal that stimulates behavioral immunity and aversive learning. Commun Biol 5(1):422, 2022. e-Pub 2022. PMID: 35513700.
      8. Sang Y, Ren J, Aballay A. The transcription factor HLH-26 controls probiotic-mediated protection against intestinal infection through up-regulation of the Wnt/BAR-1 pathway. PLoS Biol 20(3):e3001581, 2022. e-Pub 2022. PMID: 35263319.
      9. Kaur S, Sang Y, Aballay A. Myotubularin-related protein protects against neuronal degeneration mediated by oxidative stress or infection. J Biol Chem 298(3):101614, 2022. e-Pub 2022. PMID: 35101447.
      10. Filipowicz A, Lalsiamthara J, Aballay A. TRPM channels mediate learned pathogen avoidance following intestinal distention. Elife 10, 2021. e-Pub 2021. PMID: 34032213.
      11. Otarigho B, Aballay A. Immunity-longevity tradeoff neurally controlled by GABAergic transcription factor PITX1/UNC-30. Cell Rep 35(8):109187, 2021. e-Pub 2021. PMID: 34038721.
      12. Hong C, Lalsiamthara J, Ren J, Sang Y, Aballay A. Microbial colonization induces histone acetylation critical for inherited gut-germline-neural signaling. PLoS Biol 19(3):e3001169, 2021. e-Pub 2021. PMID: 33788830.
      13. Otarigho B, Aballay A. Cholesterol Regulates Innate Immunity via Nuclear Hormone Receptor NHR-8. iScience 23(5):101068, 2020. e-Pub 2020. PMID: 32361270.
      14. Singh J, Aballay A. Bacterial Lawn Avoidance and Bacterial Two Choice Preference Assays in Caenorhabditis elegans. Bio Protoc 10(10):e3623, 2020. e-Pub 2020. PMID: 33659296.
      15. Kaur S, Aballay A. G-Protein-Coupled Receptor SRBC-48 Protects against Dendrite Degeneration and Reduced Longevity Due to Infection. Cell Rep 31(7):107662, 2020. e-Pub 2020. PMID: 32433971.
      16. Hoffman CL, Lalsiamthara J, Aballay A. Host Mucin Is Exploited by Pseudomonas aeruginosa To Provide Monosaccharides Required for a Successful Infection. mBio 11(2), 2020. e-Pub 2020. PMID: 32127446.
      17. Singh J, Aballay A. Intestinal infection regulates behavior and learning via neuroendocrine signaling. Elife 8, 2019. e-Pub 2019. PMID: 31674907.
      18. Singh J, Aballay A. Microbial Colonization Activates an Immune Fight-and-Flight Response via Neuroendocrine Signaling. Dev Cell 49(1):89-99.e4, 2019. e-Pub 2019. PMID: 30827896.
      19. Olaitan AO, Aballay A. Non-proteolytic activity of 19S proteasome subunit RPT-6 regulates GATA transcription during response to infection. PLoS Genet 14(9):e1007693, 2018. e-Pub 2018. PMID: 30265660.
      20. Cao X, Kajino-Sakamoto R, Doss A, Aballay A. Distinct Roles of Sensory Neurons in Mediating Pathogen Avoidance and Neuropeptide-Dependent Immune Regulation. Cell Rep 21(6):1442-1451, 2017. e-Pub 2017. PMID: 29117551.
      21. Singh J, Aballay A. Endoplasmic Reticulum Stress Caused by Lipoprotein Accumulation Suppresses Immunity against Bacterial Pathogens and Contributes to Immunosenescence. mBio 8(3), 2017. e-Pub 2017. PMID: 28559483.
      22. Head BP, Olaitan AO, Aballay A. Role of GATA transcription factor ELT-2 and p38 MAPK PMK-1 in recovery from acute P. aeruginosa infection in C. elegans. Virulence 8(3):261-274, 2017. e-Pub 2017. PMID: 27600703.
      23. Martin N, Singh J, Aballay A. Natural Genetic Variation in the Caenorhabditis elegans Response to Pseudomonas aeruginosa. G3 (Bethesda) 7(4):1137-1147, 2017. e-Pub 2017. PMID: 28179390.
      24. Wyatt LH, Luz AL, Cao X, Maurer LL, Blawas AM, Aballay A, Pan WK, Meyer JN. Effects of methyl and inorganic mercury exposure on genome homeostasis and mitochondrial function in Caenorhabditis elegans. DNA Repair (Amst) 52:31-48, 2017. e-Pub 2017. PMID: 28242054.
      25. Gomez-Pastor R, Burchfiel ET, Neef DW, Jaeger AM, Cabiscol E, McKinstry SU, Doss A, Aballay A, Lo DC, Akimov SS, Ross CA, Eroglu C, Thiele DJ. Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington's disease. Nat Commun 8:14405, 2017. e-Pub 2017. PMID: 28194040.
      26. Cao X, Aballay A. Neural Inhibition of Dopaminergic Signaling Enhances Immunity in a Cell-Non-autonomous Manner. Curr Biol 26(17):2329-34, 2016. e-Pub 2016. PMID: 27524480.
      27. Wu Q, Cao X, Yan D, Wang D, Aballay A. Genetic Screen Reveals Link between the Maternal Effect Sterile Gene mes-1 and Pseudomonas aeruginosa-induced Neurodegeneration in Caenorhabditis elegans. J Biol Chem 290(49):29231-9, 2015. e-Pub 2015. PMID: 26475858.
      28. Head B, Aballay A. Recovery from an acute infection in C. elegans requires the GATA transcription factor ELT-2. PLoS Genet 10(10):e1004609, 2014. e-Pub 2014. PMID: 25340560.
      29. Cai Y, Cao X, Aballay A. Whole-animal chemical screen identifies colistin as a new immunomodulator that targets conserved pathways. mBio 5(4), 2014. e-Pub 2014. PMID: 25118236.
      30. Singh V, Aballay A. Endoplasmic reticulum stress pathway required for immune homeostasis is neurally controlled by arrestin-1. J Biol Chem 287(40):33191-7, 2012. e-Pub 2012. PMID: 22875856.
      31. Sun J, Liu Y, Aballay A. Organismal regulation of XBP-1-mediated unfolded protein response during development and immune activation. EMBO Rep 13(9):855-60, 2012. e-Pub 2012. PMID: 22791024.
      32. Sun J, Singh V, Kajino-Sakamoto R, Aballay A. Neuronal GPCR controls innate immunity by regulating noncanonical unfolded protein response genes. Science 332(6030):729-32, 2011. e-Pub 2011. PMID: 21474712.
      33. Means TK, Aballay A. Models to study ancient host-pathogen interactions: lessons from Crete. EMBO Rep 12(1):5-7, 2011. e-Pub 2011. PMID: 21164515.
      34. TeKippe M, Aballay A. C. elegans germline-deficient mutants respond to pathogen infection using shared and distinct mechanisms. PLoS One 5(7):e11777, 2010. e-Pub 2010. PMID: 20668681.
      35. Bolz DD, Tenor JL, Aballay A. A conserved PMK-1/p38 MAPK is required in caenorhabditis elegans tissue-specific immune response to Yersinia pestis infection. J Biol Chem 285(14):10832-40, 2010. e-Pub 2010. PMID: 20133945.
      36. Singh V, Aballay A. Regulation of DAF-16-mediated Innate Immunity in Caenorhabditis elegans. J Biol Chem 284(51):35580-7, 2009. e-Pub 2009. PMID: 19858203.
      37. Fuhrman LE, Goel AK, Smith J, Shianna KV, Aballay A. Nucleolar proteins suppress Caenorhabditis elegans innate immunity by inhibiting p53/CEP-1. PLoS Genet 5(9):e1000657, 2009. e-Pub 2009. PMID: 19763173.
      38. Aballay A. Neural regulation of immunity: role of NPR-1 in pathogen avoidance and regulation of innate immunity. Cell Cycle 8(7):966-9, 2009. e-Pub 2009. PMID: 19270528.
      39. Styer KL, Singh V, Macosko E, Steele SE, Bargmann CI, Aballay A. Innate immunity in Caenorhabditis elegans is regulated by neurons expressing NPR-1/GPCR. Science 322(5900):460-4, 2008. e-Pub 2008. PMID: 18801967.
      40. Fuhrman LE, Shianna KV, Aballay A. High-throughput isolation and mapping of C. elegans mutants susceptible to pathogen infection. PLoS One 3(8):e2882, 2008. e-Pub 2008. PMID: 18682730.
      41. Haskins KA, Russell JF, Gaddis N, Dressman HK, Aballay A. Unfolded protein response genes regulated by CED-1 are required for Caenorhabditis elegans innate immunity. Dev Cell 15(1):87-97, 2008. e-Pub 2008. PMID: 18606143.
      42. Bartra SS, Styer KL, O'Bryant DM, Nilles ML, Hinnebusch BJ, Aballay A, Plano GV. Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein. Infect Immun 76(2):612-22, 2008. e-Pub 2008. PMID: 18025094.
      43. Styer KL, Click EM, Hopkins GW, Frothingham R, Aballay A. Study of the role of CCR5 in a mouse model of intranasal challenge with Yersinia pestis. Microbes Infect 9(9):1135-8, 2007. e-Pub 2007. PMID: 17644454.
      44. Kerry S, TeKippe M, Gaddis NC, Aballay A. GATA transcription factor required for immunity to bacterial and fungal pathogens. PLoS One 1(1):e77, 2006. e-Pub 2006. PMID: 17183709.
      45. Singh V, Aballay A. Heat-shock transcription factor (HSF)-1 pathway required for Caenorhabditis elegans immunity. Proc Natl Acad Sci U S A 103(35):13092-7, 2006. e-Pub 2006. PMID: 16916933.
      46. Burton EA, Pendergast AM, Aballay A. The Caenorhabditis elegans ABL-1 tyrosine kinase is required for Shigella flexneri pathogenesis. Appl Environ Microbiol 72(7):5043-51, 2006. e-Pub 2006. PMID: 16820504.
      47. Styer KL, Hopkins GW, Bartra SS, Plano GV, Frothingham R, Aballay A. Yersinia pestis kills Caenorhabditis elegans by a biofilm-independent process that involves novel virulence factors. EMBO Rep 6(10):992-7, 2005. e-Pub 2005. PMID: 16170309.
      48. Tenor JL, McCormick BA, Ausubel FM, Aballay A. Caenorhabditis elegans-based screen identifies Salmonella virulence factors required for conserved host-pathogen interactions. Curr Biol 14(11):1018-24, 2004. e-Pub 2004. PMID: 15182677.
      49. Aballay A, Drenkard E, Hilbun LR, Ausubel FM. Caenorhabditis elegans innate immune response triggered by Salmonella enterica requires intact LPS and is mediated by a MAPK signaling pathway. Curr Biol 13(1):47-52, 2003. e-Pub 2003. PMID: 12526744.
      50. Aballay A, Ausubel FM. Programmed cell death mediated by ced-3 and ced-4 protects Caenorhabditis elegans from Salmonella typhimurium-mediated killing. Proc Natl Acad Sci U S A 98(5):2735-9, 2001. e-Pub 2001. PMID: 11226309.
      51. Strauss E. Microbiology. Simple hosts may help reveal how bacteria infect cells. Science 290(5500):2245-7, 2000. e-Pub 2000. PMID: 11188717.
      52. Aballay A, Yorgey P, Ausubel FM. Salmonella typhimurium proliferates and establishes a persistent infection in the intestine of Caenorhabditis elegans. Curr Biol 10(23):1539-42, 2000. e-Pub 2000. PMID: 11114525.
      53. Hoffenberg S, Liu X, Nikolova L, Hall HS, Dai W, Baughn RE, Dickey BF, Barbieri MA, Aballay A, Stahl PD, Knoll BJ. A novel membrane-anchored Rab5 interacting protein required for homotypic endosome fusion. J Biol Chem 275(32):24661-9, 2000. e-Pub 2000. PMID: 10818110.
      54. Arenas GN, Staskevich AS, Aballay A, Mayorga LS. Intracellular trafficking of Brucella abortus in J774 macrophages. Infect Immun 68(7):4255-63, 2000. e-Pub 2000. PMID: 10858243.
      55. Aballay A, Stahl PD, Mayorga LS. Phorbol ester promotes endocytosis by activating a factor involved in endosome fusion. J Cell Sci 112 ( Pt 15):2549-57, 1999. e-Pub 1999. PMID: 10393811.
      56. Aballay A, Barbieri MA, Colombo MI, Arenas GN, Stahl PD, Mayorga LS. A phorbol ester-binding protein is required downstream of Rab5 in endosome fusion. FEBS Lett 441(3):373-8, 1998. e-Pub 1998. PMID: 9891974.
      57. Aballay A, Arenas NG, Quest AF, Mayorga LS. A factor with a zinc- and phorbol ester-binding domain is necessary for endosome fusion. Exp Cell Res 235(1):28-34, 1997. e-Pub 1997. PMID: 9281349.
      58. Aballay A, Sarrouf MN, Colombo MI, Stahl PD, Mayorga LS. Zn2+ depletion blocks endosome fusion. Biochem J 312 ( Pt 3)(Pt 3):919-23, 1995. e-Pub 1995. PMID: 8554539.

      Review Articles

      1. Singh J, Aballay A. Neural control of behavioral and molecular defenses in C. elegans. Curr Opin Neurobiol 62:34-40, 2020. e-Pub 2020. PMID: 31812835.
      2. Hoffman C, Aballay A. Role of neurons in the control of immune defense. Curr Opin Immunol 60:30-36, 2019. e-Pub 2019. PMID: 31117013.
      3. Singh J, Aballay A. Similar Neural Pathways Control Foraging in Mosquitoes and Worms. mBio 10(2), 2019. e-Pub 2019. PMID: 31040241.
      4. Aballay A. Role of the nervous system in the control of proteostasis during innate immune activation: insights from C. elegans. PLoS Pathog 9(8):e1003433, 2013. e-Pub 2013. PMID: 23950707.
      5. Singh V, Aballay A. Heat shock and genetic activation of HSF-1 enhance immunity to bacteria. Cell Cycle 5(21):2443-6, 2006. e-Pub 2006. PMID: 17106259.
      6. Mylonakis E, Aballay A. Worms and flies as genetically tractable animal models to study host-pathogen interactions. Infect Immun 73(7):3833-41, 2005. e-Pub 2005. PMID: 15972468.
      7. Aballay A, Arenas GN, Mayorga LS. Calcium- and zinc-binding proteins in intracellular transport. Biocell 20(3):339-42, 1996. e-Pub 1996. PMID: 9031603.

      Book Chapters

      1. Filipowicz, A, Aballay, A, Singh, V. Cellular and Organismal Responses to Infections in Caenorhabditis elegans, 463-477, 2022.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Aballay Laboratory

      • Genetics department

      • Discovery Science division

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top